Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of FPR3 as a Unique Biomarker for Targeted Therapy in the Immune Microenvironment of Breast Cancer

11 Feb 2021

Abstract excerpt

Although research into immunotherapy is growing, its use in the treatment of breast cancer remains limited. Thus, identification and evaluation of prognostic biomarkers of tissue microenvironments will reveal new immune-based therapeutic strategies for breast cancer. Using an in silico bioinformatic approach, we investigated the tumor microenvironmental and genetic factors related to breast cancer. We calculated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to S100 Proteins and Annexins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33679387
DOI: 10.3389/fphar.2020.593247

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of FPR3 as a Unique Biomarker for Targeted Therapy in the Immune Microenvironment of Breast CancerPMID 33679387Read ↗

Identification of FPR3 as a unique biomarker for targeted therapy in the immune microenvironment of breast cancerSemantic proximity Read ↗

Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancerSemantic proximity Read ↗

Recognition of Immune Microenvironment Landscape and Immune-Related Prognostic Genes in Breast Cancer.Semantic proximity Read ↗

CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor MicroenvironmentSemantic proximity Read ↗

Exploring immune-related genes with prognostic value in microenvironment of breast cancer from TCGA databaseSemantic proximity Read ↗

Characterizing the Tumor Microenvironment and Its Prognostic Impact in Breast Cancer.Semantic proximity Read ↗

Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer.Semantic proximity Read ↗

Identification of prognostic genes from the breast cancer microenvironmentSemantic proximity Read ↗

A Framework to Predict the Molecular Classification and Prognosis of Breast Cancer Patients and Characterize the Landscape of Immune Cell Infiltration.Semantic proximity Read ↗

Immune cell infiltration-based signature for prognosis and immunogenomic analysis in breast cancer.Semantic proximity Read ↗

Machine Learning Reveals Genetic Modifiers of the Immune Microenvironment of CancerSemantic proximity Read ↗

Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.